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C. asiatica herb is recommended in the treatment of dermatoses and skin lesions such as 
excoriations, burns, hypertrophic scars or eczema as well as in non-dermatological diseases 
like gastric ulcers, gastric mucosal lesions (Shinomol and Muralidhara, 2011), anxiety 
(Wijeweeraa et al., 2006) and for improving cog-nition in neurodegenerative disorders 
(Subathra et al., 2005). C. asiatica has also been found beneficial in chronic venous 
insufficiency, mainly by improvement of microcirculation (Chong and Aziz, 2013). C. asiatica 
extract (International Nomenclature of Cosmetic Ingre-dients, INCI) is used also as an 
ingredient of cosmetics (Bylka et al., 2013).  
Many studies present activity of C. asiatica, but until now there have been no reviews 
presenting the scientific information about the usage of H. asiatica in dermato-logical diseases. 
For this reason, this study provides an overview of the current knowledge on the in vitro and 
in vivo experiments, focused on the activity of C. asiatica extracts and individual compounds 
in facilitating the process of healing wounds, psoriasis and scleroderma lesions. The 
mechanisms of the above-mentioned activ-ities as well as the potential side effects are 
discussed. 
 
 
 
CHEMICAL CONSTITUENTS 
Ursane type pentacyclic triterpenoids known as centelloids, mainly: asiaticoside, 
madecasosside (brahminoside), asiatic acid and madecassic acid (brahmic acid) (Fig. 1) were 
the most important constituents isolated from C. asiatica. Other triterpenoids in Gotu kola 
include: asiaticoside C, D, E, F; centellasaponin B, C; isothankunic acid and oleanane type 
saponins, e.g. terminolic acid; centellasaponin D. C. asiatica contains about 0.1% essential oils 
with α-humulene, germacrene B/D, β-caryphyllene, flavonoids, sesquiter-penes, steroids 
(Brinkhaus et al., 2000; James and Duebery, 2009; James and Dubery, 2011; Nhiem et al., 
2011). Sapo-nins may account for 1% to 8%, according to the European Pharmacopoeia, not 
less than 6.0% (Ph.Eur. 2011). 
 
Pharmacological and clinical studies were carried out on the defined extracts as well as 
undefined aqueous or alco-hol extracts (Table 1). However, information on the medicinal 
products suggests that all extracts: titrated ex-tract of C. asiatica (TECA), total triterpenoid 
fraction of C. asiatica (TTFCA), total triterpenic fraction (TTF), as well as C. asiatica total 
triterpenic fraction (CATTF) and estratto titolato di C. asiatica (ETCA) are different acro-nyms 
of the same extract, contained in the used prepara-tions: Madecassol®, Centellase® or 
Blastoestimulina®. These extracts include 40% of asiaticoside and a 60% mixture of asiatic 
and madecassic acids (Brinkhaus et al., 2000; EMEA (European Medicines Agency), 2012).  
One to two tablets (10 mg/tabl.) three times a day for adults and a half of this dose for children 
under 3 years of age are recommended by the European Medicines Agency (EMEA) in the 
case of non-healing wounds, hy-pertrophic scars or keloids in the active phase. For external 
use, to support the local treatment and to improve the granulation phase of non-healing ulcers 
and wounds, 1% cream is recommended. Disinfection of the wound/ulcer is required before 
treatment with TTFCA. Moreover, 1% ointment and 2% powder are available for the treatment 
of non-healing wounds. 
 
 
In vitro experiments 
 
Wound healing. Wound healing is a complex biological process involving coagulation, 
inflammation, cytokine production, cell migration, proliferation and differentia-tion, 
angiogenesis, synthesis and remodeling of extracel-lular matrix (including collagen production 
and deposition). Type I and III collagen are the major com-ponents of the skin extracellular 
matrix. Both types play an important role in the wound healing process. As a result, 
proliferation of epithelial cells and wound con-traction occur (Lu et al., 2004a, 2004b; Liu et 
al., 2008).  
C. asiatica extracts, individual triterpene compounds and the mixture of triterpenoids from 
C. asiatica have been proven to support wound healing in a large num-ber of scientific reports.  
A statistically significant increase in the percentage of collagen and cell layer fibronectin in 
cultures of human skin fibroblasts, after application of TTFCA extract (25 μg/mL), was 
detected (Tenni et al., 1988).  
The TECA and its components including asiatic acid, madecassic acid and asiaticoside have 
been studied on human foreskin fibroblast monolayer cultures. TECA increased the collagen 
synthesis in a dose-dependent manner. In addition, TECA and all terpenes increased the 
intracellular free proline level, but this effect was independent of the stimulation of collagen 
synthesis (Maquart et al., 1990).  
The influence of asiatic acid, madecassic acid and asiaticoside on human skin fibroblast type 
I collagen syn-thesis was investigated in vitro separately for each agent and in combination. 
Additionally, the culture was or was not stimulated with ascorbic acid. In the presence of 
ascorbic acid, secretion of type I collagen was higher for each individual component and for 
the mixture, than in the absence of ascorbic acid (Bonté et al., 1994). 
  
To determine secretion of type I and III collagen in human fibroblast culture with or without 
stimulation with asiaticoside and madecassoside, the enzyme-linked immunosorbent assay 
(ELISA) was performed. The secretion of type I collagen was increased for 25–30% with 
asiaticoside and madecassoside. Authors concluded that C. asiatica extracts may facilitate 
maturity of a scar by increasing the amount of type I collagen and thus in-creasing the type 
I:III collagen ratio (Bonté et al., 1995).  
 
Lee et al. (2006) have shown that asiaticoside signifi-cantly induced type I collagen synthesis 
in human der-mal fibroblast. 
The influence of asiaticoside on collagen synthesis and keloid-derived fibroblast proliferation 
was also investigated by Tang et al. (2011). The ethanolic extract of C. asiatica enhanced three-
fold collagen synthesis of human fibroblast cells com-pared to the control. The highest collagen 
synthesis was found at 50 mg/mL of C. asiatica extract. This ex-tract demonstrated significant 
DPPH-radical scavenging activity with 84% inhibition at a concentration 1 mg/mL. The 
activity was compared to that of grape seed extract and vitamin C (Hashim et al., 2011). 
 
Asiaticoside enhanced periodontal tissue healing on human periodontal ligament cells 
(HPDLs). Dose-dependent increases in the levels of mRNA and protein of fibronectin and type 
I collagen, as well as attenuated metalloproteinase-I mRNA expression, were observed when 
HPDLs were treated by asiaticoside. Further-more, asiaticoside promoted osteogenic 
differentiation of HPDLs (Nowwarote et al., 2013). 
 
 
Clinical study 
 
Scleroderma. Guseva et al. (1998) studied the efficacy of orally/topically administered 
madecassol in patients with systemic sclerosis (SSc) and localized scleroderma (LS). They 
found that 6 month oral course (30 mg/day) caused softening of the skin lesions, lightening of 
hyperpigmentation and improvement of general condi-tion of 12 SSc patients. 
 
 
Wound healing. C. asiatica extract can shorten the healing process of wound in diabetic 
patients. The ran-domized control study included 200 diabetic patients, treated with two 
capsules of C. asiatica extract (50 mg asiaticoside/capsule) three times a day. Results showed 
that wound contraction was better than in the placebo group. Moreover, the extract suppresses 
the formation of scar tissue (Paocharoen, 2010). 
 
Scleroderma. Guseva et al. (1998) studied the efficacy of orally/topically administered 
madecassol in patients with systemic sclerosis (SSc) and localized scleroderma (LS). They 
found that 6 month oral course (30 mg/day) caused softening of the skin lesions, lightening of 
hyperpigmentation and improvement of general condi-tion of 12 SSc patients. 
 
Conclusion  
the effectiveness of C. asiatica and its preparation in facilitating the wound healing. More-
over, available literature does not clarify the best route and dosage of administration of the C. 
asiatica extract. In order to evaluate the usefulness of the plant in this area, clinical trials 
should be carried out. 
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